| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8d175d6dd59db1999896be7b5daf331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ad98319d8dac24ab18054e1f28f810c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_577821cf81fda3e1088e6ed08bcd136b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2010-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffad39b6635b16a9238967a91f678330
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f559aaeaf0068864b9af9b2c1dfba6f9 |
| publicationDate |
2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011029946-A1 |
| titleOfInvention |
A proteolytic product of histone h2a as a marker for cancer |
| abstract |
The present invention relates to proteolytic products of histone H2A. In particular, the present invention discloses a peptide having the amino acid sequence VTIAQGGVLPNIQAV which can be used to determine cleavage of histone H2A. More in particular, the present invention relates to the latter peptide as a marker to diagnose or to determine prognosis of cancer such as chronic lymphocytic leukemia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103529138-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11391742-B2 |
| priorityDate |
2009-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |